Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children with Idiopathic Short Stature

Project: Research

Project Details

StatusActive
Effective start/end date10/18/24 → 11/30/26

Funding

  • BioMarin Pharmaceutical Incorporated: $112,991.87